EASL General Assembly elects new Board and Committee members
The General Assembly of the European Association for the Study of the Liver (EASL) has elected new members to its Governing Board, various committees and a new Editor-In-Chief for its Journal of…
Experts warn of fatty liver disease in young people
New research, presented at the International Liver Congress™, warns that high levels of non-alcoholic fatty liver disease among young people is signalling a public health crisis. Excerpt from The Guardian Study finds…
First articles available on new open access journal JHEP Reports
The latest journal from EASL, JHEP Reports is fully open access.Our goal is to become an essential channel for innovation in hepatology by publishing outstanding basic, translational and clinical studies.
Treatment with high doses of albumin improves cardiac function and reduces systemic inflammation in patients with decompensated cirrhosis
According to a study conducted by the EF-Clif published in Gastroenterology This study has shown for the first time that the administration of albumin at high doses has an immunomodulatory effect both…
The WHO guidelines for chronic hepatitis B fail to detect half of the patients in need of treatment in Ethiopia
A revision is proposed for current WHO guidelines for chronic hepatitis B (CHB) as they fail to detect half of the patients in need of treatment in Ethiopia
Antiviral therapy improves survival rates for kidney transplant recipients with hepatitis B or C
In a new study in the Journal of Hepatology, researchers report favorable 10-year survival rates for patients with HBV and/or HCV treated with antiviral agents and advise that antiviral therapy should be systematically offered to all HBV and HCV patients in line with international recommendations.
Tenofovir resistance in patients with HBV
It is estimated that 2 billion people are infected with hepatitis B virus (HBV) globally, with 686,000 people dying from complications of the disease each year.